title: JC viremia in natalizumab-treated patients with multiple sclerosis.
authors.forename: Eugene O
authors.initials: EO
authors.lastname: Major
authors.forename: Elliot
authors.initials: E
authors.lastname: Frohman
authors.forename: Daniel
authors.initials: D
authors.lastname: Douek
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D006801:Humans; D007577:JC Virus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology*; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D000069442:Natalizumab; D027601:Polyomavirus Infections / Q000175:diagnosis* / Q000209:etiology; D014766:Viremia / Q000209:etiology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000914:Antibodies, Viral; D004279:DNA, Viral; D000069442:Natalizumab